BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7536090)

  • 1. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone.
    Tönshoff B; Blum WF; Vickers M; Kurilenko S; Mehls O; Ritz E
    Eur J Endocrinol; 1995 Apr; 132(4):433-7. PubMed ID: 7536090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
    Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor I.
    Fielder PJ; Gargosky SE; Vaccarello M; Wilson K; Cohen P; Diamond F; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG
    Acta Paediatr Suppl; 1993 Mar; 388():40-3; discussion 44. PubMed ID: 7687170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Hall K; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions.
    Nonoshita LD; Wathen NC; Dsupin BA; Chard T; Giudice LC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1249-55. PubMed ID: 7525630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO; Blum WF; Møller N; Ranke MB; Christiansen JS
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.
    Blum WF; Ranke MB; Kietzmann K; Tönshoff B; Mehls O
    Pediatr Nephrol; 1991 Jul; 5(4):539-44. PubMed ID: 1716946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J; Barrios V; Pozo J; Muñoz MT; Hervás F; Stene M; Hernández M
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive insulin-like growth factor II in urine.
    Zumkeller W; Hall K
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):499-503. PubMed ID: 1701609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.
    Gill MS; Whatmore AJ; Tillman V; White A; Addison GM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):483-92. PubMed ID: 9196612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
    Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
    Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
    J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women.
    Breier BH; Milsom SR; Blum WF; Schwander J; Gallaher BW; Gluckman PD
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):427-35. PubMed ID: 7506471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.